Heuts Esther M, van der Ent Fred W C, van der Pol Harry A G, Debets Joop M H, Kengen Roland A M, Verkeyn Joost M A, Hulsewé Karel W E, Hoofwijk Anton G M
Department of Surgery, Maaslandziekenhuis, Sittard, the Netherlands.
Nucl Med Commun. 2006 Aug;27(8):677-81. doi: 10.1097/00006231-200608000-00010.
Metastases in the internal mammary lymph nodes have an important prognostic value in breast cancer. Lymphatic mapping and sentinel node biopsy of internal mammary nodes improves staging and permits specific therapeutic strategies, thereby possibly improving final outcome. Therefore, optimal lymphoscintigraphic results are needed. Visualization of internal mammary lymph drainage, however, is influenced by several factors. We evaluated the effect of different time intervals between radioactive tracer injection and lymphoscintigraphy on visualization of internal mammary sentinel lymph nodes.
From February 1997 to August 2001 a total of 682 eligible breast cancer patients underwent sentinel lymph node mapping. The technique involved the injection of 370 MBq (10 mCi) (99m)Tc-nanocolloid peritumorally. In 470 patients (group A) the time interval between injection of the radiocolloid and lymphoscintigraphy was 16 h, compared to 2.5 h in 212 patients (group B).
Patient characteristics showed no statistically significant difference between both groups for age and location of the tumour. Axillary hotspots were visualized in 97% in group A and 96% in group B. Lymphoscintigraphy showed internal mammary hotspots in 21% in group A, compared to 27% in group B. The mean number of internal mammary hotspots per patient was 1.9 in group A and 1.8 in group B.
We found no significant differences between early and delayed lymphoscintigraphic imaging in visualizing internal mammary sentinel lymph nodes.
内乳淋巴结转移在乳腺癌中具有重要的预后价值。内乳淋巴结的淋巴绘图和前哨淋巴结活检可改善分期,并允许采用特定的治疗策略,从而可能改善最终结局。因此,需要获得最佳的淋巴闪烁造影结果。然而,内乳淋巴引流的可视化受到多种因素的影响。我们评估了放射性示踪剂注射与淋巴闪烁造影之间不同时间间隔对内乳前哨淋巴结可视化的影响。
1997年2月至2001年8月,共有682例符合条件的乳腺癌患者接受了前哨淋巴结绘图。该技术包括在肿瘤周围注射370 MBq(10 mCi)的(99m)Tc-纳米胶体。470例患者(A组)放射性胶体注射与淋巴闪烁造影之间的时间间隔为16小时,而212例患者(B组)为2.5小时。
两组患者的年龄和肿瘤位置在统计学上无显著差异。A组腋窝热点可视化率为97%,B组为96%。淋巴闪烁造影显示A组内乳热点为21%,B组为27%。A组每位患者内乳热点的平均数量为1.9个,B组为1.8个。
我们发现在内乳前哨淋巴结可视化方面,早期和延迟淋巴闪烁造影成像之间没有显著差异。